By Yasin Gungor
ISTANBUL (AA) - A pharmaceutical executive fainted Thursday at the White House during President Donald Trump's announcement on weight loss drug costs, prompting immediate medical intervention from Dr. Mehmet Oz.
Gordon Findlay, a Novo Nordisk representative, collapsed as Eli Lilly CEO David Ricks was speaking at the Oval Office event where Trump and drugmakers were announcing a deal to expand coverage and reduce prices for obesity treatments Zepbound and Wegovy.
Dr. Oz, a professional physician who serves as administrator of the Centers for Medicare and Medicaid Services in the Trump administration, immediately responded to assist Findlay along with others in the room.
Health and Human Services Secretary Robert F. Kennedy Jr. was also present but quickly left the scene.
Journalists were escorted from the room, and the broadcast was cut following the incident.
The cause of the fainting and Findlay's condition were not immediately disclosed.